Multi-analyte isolation solutions for liquid biopsy biomarkers

Liquid biopsy has emerged as a promising area in the oncology field – offering a less invasive approach to traditional tissue biopsies. Liquid biopsy samples contain a heterogenous mixture of biomolecules that could transform cancer research by aiding in the prevention, diagnosis, monitoring, and treatment of the disease. As advancements continue to unfold, researchers are seeking dependable multi-analyte approaches to understand the complexity of cancer. Thermo Fisher Scientific supports this endeavor with comprehensive oncology research workflow solutions, featuring robust sample preparation tools and automated technologies to help advance cancer research efforts for discovery to diagnostic development.